IRE Elit files Marketing Authorisation Application for generator Galli Eo

create 2016-11-12

Our new supplier of a 68Germanium/68Gallium generator issued a press release last week where they announced that they are filing for a MA for Galli Eo:

Fleurus, Belgium November 2th, 2016 – IRE Elit, the IRE subsidiary specialised in the production of radiopharmaceuticals, is pleased to announce the filing of a marketing authorisation (MAA) application with the European Medicines Agency (EMA) for the Galli Eo, a radiopharmaceutical 68Germanium/68Gallium generator that constitutes major progress in the availability and routine use of Gallium-68 by nuclear medicine centres.

To read the full press release go to IRE P.R. MA Galli Eo